GMED (GMED) AIQ Analysis
GMED scores 68/100 with Smart Score 10/10 and Sharpe 0.63.
AIQ Brief
GMED is currently in a mixed setup with AIQ 68/100 and Smart 10/10 (strong relative) at $95.25. Risk is elevated. Read this as a prioritization signal, then confirm entry quality and sizing with your own risk plan.
Momentum is the strongest contributor at 78/100, while Value is the binding constraint at 53/100. With a 25-point spread, the profile is imbalanced, so patience and entry discipline are more important than speed.
GMED ranks 4/4 in this peer set (68 vs peer average 72.0). On risk-adjusted efficiency, Sharpe is below peer average (0.63 vs 2.03). This helps distinguish true relative leadership from broad sector drift.
Action now: this is a neutral/selective setup. Improve entry quality by waiting for momentum acceleration or a better risk profile before adding. Keep sizing moderate until factors align.
Sharpe is 0.63, indicating modest risk-adjusted return.
| AIQ Component | Score | Signal Read |
|---|---|---|
| Momentum | 78 | Strong trend persistence and positive acceleration. |
| Value | 53 | Valuation appears close to fair value. |
| Quality | 72 | Profitability and consistency profile is strong. |
| Risk | 75 | Risk profile is elevated; position sizing matters. |
| Sentiment | — | Sentiment signal is currently unavailable. |
Current AIQ Read
GMED currently screens as neutral. Wait for confirmation from trend quality and risk conditions before increasing exposure.
Loading GMED analysis...